The group of Van Kooyk and colleagues recently published the review “Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation” in Molecular Immunology.
The review describes the current and future directions of glycan based targeting strategies used to improve anti-tumor responses by targeting multivalent glycan-antigen formulations to Dendritic Cells.